17879400

Source:http://linkedlifedata.com/resource/pubmed/id/17879400

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021747, umls-concept:C0034656, umls-concept:C0205390, umls-concept:C0231174, umls-concept:C0524910, umls-concept:C0936233, umls-concept:C1274040, umls-concept:C1696465, umls-concept:C1879713
pubmed:issue	40
pubmed:dateCreated	2007-9-19
pubmed:abstractText	To assess the safety and efficacy of antioxidant therapy for patients with chronic hepatitis C virus (HCV) infection.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883448
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants, http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases, http://linkedlifedata.com/resource/pubmed/chemical/Interferons, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1007-9327
pubmed:author	pubmed-author:CohenRobertR, pubmed-author:GabbayEzraE, pubmed-author:HemedNilaN, pubmed-author:IlanYaronY, pubmed-author:PappoOritO, pubmed-author:RoweMinaM, pubmed-author:ZabreckyGeorgeG, pubmed-author:ZigmondEhudE
pubmed:issnType	Print
pubmed:day	28
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5317-23
pubmed:meshHeading	pubmed-meshheading:17879400-Administration, Oral, pubmed-meshheading:17879400-Adult, pubmed-meshheading:17879400-Aged, pubmed-meshheading:17879400-Alanine Transaminase, pubmed-meshheading:17879400-Antioxidants, pubmed-meshheading:17879400-Aspartate Aminotransferases, pubmed-meshheading:17879400-Biopsy, pubmed-meshheading:17879400-Double-Blind Method, pubmed-meshheading:17879400-Female, pubmed-meshheading:17879400-Hepacivirus, pubmed-meshheading:17879400-Hepatitis C, Chronic, pubmed-meshheading:17879400-Humans, pubmed-meshheading:17879400-Injections, Intravenous, pubmed-meshheading:17879400-Interferons, pubmed-meshheading:17879400-Liver, pubmed-meshheading:17879400-Male, pubmed-meshheading:17879400-Middle Aged, pubmed-meshheading:17879400-RNA, Viral
pubmed:year	2007
pubmed:articleTitle	Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.
pubmed:affiliation	Liver Unit, Department of Medicine, Hebrew University, Hadassah Medical Center, POB 12000, Jerusalem IL-91120, Israel.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II